| A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B P Piccolo, I Lenci, L Demelia, F Bandiera, MR Piras, G Antonucci, ... Antiviral therapy 14 (8), 1165-1174, 2009 | 138 | 2009 |
| A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C M Angelico, A Petrolati, R Lionetti, I Lenci, P Burra, MF Donato, M Merli, ... Journal of hepatology 46 (6), 1009-1017, 2007 | 106 | 2007 |
| Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late AM Pellicelli, M Montalbano, R Lionetti, C Durand, P Ferenci, G D’Offizi, ... Digestive and Liver Disease 46 (10), 923-927, 2014 | 103 | 2014 |
| Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ... Liver international 37 (4), 514-528, 2017 | 99 | 2017 |
| Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence I Lenci, G Tisone, D Di Paolo, F Marcuccilli, L Tariciotti, M Ciotti, V Svicher, ... Journal of hepatology 55 (3), 587-593, 2011 | 94 | 2011 |
| Liver transplantation for hepatocellular carcinoma: Where do we stand? F Santopaolo, I Lenci, M Milana, TM Manzia, L Baiocchi World journal of gastroenterology 25 (21), 2591, 2019 | 91 | 2019 |
| Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation I Lenci, A Alvior, TM Manzia, L Toti, J Neuberger, R Steeds Journal of the American Society of Echocardiography 22 (1), 89-94, 2009 | 74 | 2009 |
| Low-dose hepatitis B immunoglobulin given “on demand” in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the … D Di Paolo, G Tisone, P Piccolo, I Lenci, S Zazza, M Angelico Transplantation 77 (8), 1203-1208, 2004 | 67 | 2004 |
| Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: a pilot study L Toti, M Attia, TM Manzia, I Lenci, B Gunson, JAC Buckels, DF Mirza, ... Digestive and Liver Disease 42 (3), 205-209, 2010 | 55 | 2010 |
| De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature TM Manzia, R Angelico, C Gazia, I Lenci, M Milana, OT Ademoyero, ... World Journal of Gastroenterology 25 (35), 5356, 2019 | 54 | 2019 |
| Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis I Lenci, F Marcuccilli, G Tisone, D Di Paolo, L Tariciotti, M Ciotti, T Guenci, ... Digestive and Liver Disease 42 (8), 578-584, 2010 | 54 | 2010 |
| One‐year vaccination against hepatitis B virus with a MPL‐vaccine in liver transplant patients for HBV‐related cirrhosis D Di Paolo, I Lenci, C Cerocchi, L Tariciotti, A Monaco, A Brega, L Lotti, ... Transplant International 23 (11), 1105-1112, 2010 | 50 | 2010 |
| Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C virus genotypes 1–4 in Italy A Bertoli, MC Sorbo, M Aragri, I Lenci, E Teti, E Polilli, VC Di Maio, ... Scientific reports 8 (1), 8988, 2018 | 49 | 2018 |
| Liver transplantation performed in a SARS‐CoV‐2 positive hospitalized recipient using a SARS‐CoV‐2 infected donor TM Manzia, C Gazia, I Lenci, R Angelico, L Toti, A Monaco, A Anselmo, ... American Journal of Transplantation 21 (7), 2600-2604, 2021 | 43 | 2021 |
| Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis M Guarino, L Viganò, FR Ponziani, EG Giannini, Q Lai, F Morisco, A Vitale, ... Digestive and Liver Disease 50 (11), 1105-1114, 2018 | 39 | 2018 |
| Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? VC Di Maio, V Cento, M Aragri, S Paolucci, T Pollicino, N Coppola, ... Journal of hepatology 68 (3), 597-600, 2018 | 39 | 2018 |
| Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept A Vitale, G Cabibbo, M Iavarone, L Viganò, DJ Pinato, FR Ponziani, Q Lai, ... The Lancet Oncology 24 (7), e312-e322, 2023 | 34 | 2023 |
| Dual role of bile acids on the biliary epithelium: friend or foe? L Baiocchi, T Zhou, S Liangpunsakul, I Lenci, F Santopaolo, F Meng, ... International Journal of Molecular Sciences 20 (8), 1869, 2019 | 34 | 2019 |
| Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of endoscopic ultrasound fine needle aspiration TM Manzia, L Toti, I Lenci, M Attia, L Tariciotti, SR Bramhall, JAC Buckels, ... The Annals of The Royal College of Surgeons of England 92 (4), 295-301, 2010 | 34 | 2010 |
| Massive hepatic angiomyolipoma in a young woman with tuberous sclerosis complex: significant clinical improvement during tamoxifen treatment I Lenci, M Angelico, G Tisone, A Orlacchio, G Palmieri, M Pinci, ... Journal of hepatology 48 (6), 1026-1029, 2008 | 30 | 2008 |
